News
BEATW
0.0070
-27.84%
-0.0027
Heartbeam Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones · 4d ago
HC Wainwright & Co. Downgrades HeartBeam to Neutral
Benzinga · 4d ago
HeartBeam downgraded to Neutral from Buy at H.C. Wainwright
TipRanks · 4d ago
HeartBeam says redirecting resources to myocardial infarction detection
TipRanks · 5d ago
Weekly Report: what happened at BEAT last week (0914-0918)?
Weekly Report · 5d ago
HeartBeam, Inc. Letter to Shareholders
Barchart · 5d ago
Weekly Report: what happened at BEAT last week (0907-0911)?
Weekly Report · 09/14 10:06
Weekly Report: what happened at BEAT last week (0831-0904)?
Weekly Report · 09/07 10:00
Weekly Report: what happened at BEAT last week (0824-0828)?
Weekly Report · 08/31 10:06
Weekly Report: what happened at BEAT last week (0817-0821)?
Weekly Report · 08/24 10:07
HeartBeam Earnings Call: Fast Trials, Slow Revenue Build
TipRanks · 08/22 00:27
HeartBeam Buy Rating Reiterated as Clinical and Commercial Momentum Strengthens; $2 Price Target Maintained
TipRanks · 08/18 16:55
Weekly Report: what happened at BEAT last week (0810-0814)?
Weekly Report · 08/17 10:07
HeartBeam Launches New At-The-Market Equity Offering
TipRanks · 08/14 21:28
HeartBeam Enters ATM Equity Offering Agreement To Sell Up To $25M Of Common Stock Through Titan Partners Securities
Benzinga · 08/14 21:07
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 08/14 17:06
Analysts Offer Insights on Healthcare Companies: Icecure Medical (ICCM) and HeartBeam (BEAT)
TipRanks · 08/14 11:50
HeartBeam GAAP EPS of -$0.10 misses by $0.01
Seeking Alpha · 08/13 20:06
*Heartbeam 2Q Loss/Shr 10c >BEAT
Dow Jones · 08/13 20:01
*Heartbeam 2Q Loss $5.04M >BEAT
Dow Jones · 08/13 20:01
More
Webull provides a variety of real-time BEATW stock news. You can receive the latest news about Heartbeam through multiple platforms. This information may help you make smarter investment decisions.
About BEATW
HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.